Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Biosynthesis of Cannabinoids Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / New Technology / Global Biosynthesis of Cannabinoids Market

Global Biosynthesis of Cannabinoids Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

New Technology Feb 2019 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Biosynthesis of Cannabinoids Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

Global Biosynthesis of Cannabinoids market research report offers a complete overview of the market size, volume, and revenue. Additionally, a comprehensive detailing of the market evolution, trends, and forecast coupled with the latest growth opportunities of Biosynthesis of Cannabinoids market is also provided in the report The report also has the market details encompassed based on the product type, application, key manufacturers and key regions. This report offers comprehensive analysis on global Biosynthesis of Cannabinoids market along with market growth drivers and restraints. For obtaining a better understanding of the complete breakdown of the Biosynthesis of Cannabinoids market, an in-depth study of market size with data Tables, Graphs & Statistics, and Bar & Pie Charts are provided.

Data provided by Extent Research. Source: https://www.extentresearch.com/biosynthesis-of-cannabinoids-market

Despite the COVID-19 pandemic, there are hopes that the market will generative countless opportunities for the investors post-crisis. The report illustrates the latest developments, financial ups and downs, and COVID-19 impact on the entire Biosynthesis of Cannabinoids industry as well.

Regional Analysis:

The key regions in the Biosynthesis of Cannabinoids market include North America, Europe, Asia Pacific, Latin America, Middle East & Africa. The regional study helps provide better understanding about the market growth and status on both the regional and global level. The regional market analysis in the report offers a complete overview of the market.

Competitive Landscape Analysis:

The key players in the Biosynthesis of Cannabinoids market include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram, Teewinot Life Sciences, ICC International Cannabis Corp., Biotii Technologies Corp., Bristol-Myers Squibb, Biogen Inc., GW Pharmaceuticals, . Biosynthesis of Cannabinoids market competitive landscape provides comprehensive analysis and accurate statistics on revenue through the company profile data. The report also offers accurate and reliable statistical data. The company profile covers all the prospects such as recent developments, acquisitions, business strategies, market revenue, sales analysis, etc.

This report majorly focuses on the profound facets like supply & demand chain, pricing analysis, product launches, latest innovations, and forecast trends. The report lends versatile cues on market size, dynamics, growth traits, opportunity mapping, barrier analysis, thereby insisting report readers to observe the growth in global Biosynthesis of Cannabinoids market.

Segmentation of the Global Biosynthesis of Cannabinoids Market:

By Product type

  • THC, CBD, Others,

by Application

  • Food Industry, Medical Industry, Others,

Report Scope and Market Segmentation

ATTRIBUTES Global Biosynthesis of Cannabinoids Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Biosynthesis of Cannabinoids Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (2022-2035) 1.2.2 THC 1.2.3 CBD 1.2.4 Others 1.3 Market by Application 1.3.1 Global Biosynthesis of Cannabinoids Market Share by Application (2022-2035) 1.3.2 Food Industry 1.3.3 Medical Industry 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Biosynthesis of Cannabinoids Market Size 2.2 Biosynthesis of Cannabinoids Market Size by Regions 2.2.1 Biosynthesis of Cannabinoids Growth Rate by Regions (2022-2035) 2.2.2 Biosynthesis of Cannabinoids Market Share by Regions (2022-2035) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 Biosynthesis of Cannabinoids Revenue by Players (2022 & 2035) 3.2 Biosynthesis of Cannabinoids Key Players Headquarters and Area Served 3.3 Key Players Biosynthesis of Cannabinoids Product/Solution/Service 3.4 Date of Enter into Biosynthesis of Cannabinoids Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global Biosynthesis of Cannabinoids Market Size by Type (2022-2035) 4.2 Global Biosynthesis of Cannabinoids Market Size by Application (2022-2035) 5 North America 5.1 North America Biosynthesis of Cannabinoids Market Forecast (2022-2035) 5.2 Biosynthesis of Cannabinoids Key Players in North America 5.3 North America Biosynthesis of Cannabinoids Market Size by Type 5.4 North America Biosynthesis of Cannabinoids Market Size by Application 6 Europe 6.1 Europe Biosynthesis of Cannabinoids Market Forecast (2022-2035) 6.2 Biosynthesis of Cannabinoids Key Players in Europe 6.3 Europe Biosynthesis of Cannabinoids Market Size by Type 6.4 Europe Biosynthesis of Cannabinoids Market Size by Application 7 Asia-Pacific 7.1 Asia-Pacific Biosynthesis of Cannabinoids Market Forecast (2022-2035) 7.2 Biosynthesis of Cannabinoids Key Players in Asia-Pacific 7.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Type 7.4 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Application 8 Rest of World 8.1 Latin America 8.1.1 Latin America Biosynthesis of Cannabinoids Market Analysis 8.1.2 Key Players in Latin America 8.2 Middle East & Africa 8.2.1 Middle East & Africa Biosynthesis of Cannabinoids Market Analysis 8.2.2 Key Players in Middle East & Africa 9 International Player Profiles 9.1 Anandia Laboratories 9.1.1 Anandia Laboratories Company Details 9.1.2 Anandia Laboratories Description and Business Overview 9.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction 9.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.1.5 Anandia Laboratories Recent Development 9.2 Gingko Bioworks 9.2.1 Gingko Bioworks Company Details 9.2.2 Gingko Bioworks Description and Business Overview 9.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction 9.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.2.5 Gingko Bioworks Recent Development 9.3 Hyasynth Bio 9.3.1 Hyasynth Bio Company Details 9.3.2 Hyasynth Bio Description and Business Overview 9.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction 9.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.3.5 Hyasynth Bio Recent Development 9.4 InMed Pharmaceuticals 9.4.1 InMed Pharmaceuticals Company Details 9.4.2 InMed Pharmaceuticals Description and Business Overview 9.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction 9.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.4.5 InMed Pharmaceuticals Recent Development 9.5 Librede 9.5.1 Librede Company Details 9.5.2 Librede Description and Business Overview 9.5.3 Librede Biosynthesis of Cannabinoids Introduction 9.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.5.5 Librede Recent Development 9.6 Renew Biopharma 9.6.1 Renew Biopharma Company Details 9.6.2 Renew Biopharma Description and Business Overview 9.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction 9.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.6.5 Renew Biopharma Recent Development 9.7 Cronos Group 9.7.1 Cronos Group Company Details 9.7.2 Cronos Group Description and Business Overview 9.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction 9.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.7.5 Cronos Group Recent Development 9.8 Organigram 9.8.1 Organigram Company Details 9.8.2 Organigram Description and Business Overview 9.8.3 Organigram Biosynthesis of Cannabinoids Introduction 9.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.8.5 Organigram Recent Development 9.9 Teewinot Life Sciences 9.9.1 Teewinot Life Sciences Company Details 9.9.2 Teewinot Life Sciences Description and Business Overview 9.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction 9.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.9.5 Teewinot Life Sciences Recent Development 9.10 ICC International Cannabis Corp. 9.10.1 ICC International Cannabis Corp. Company Details 9.10.2 ICC International Cannabis Corp. Description and Business Overview 9.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction 9.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.10.5 ICC International Cannabis Corp. Recent Development 9.11 Biotii Technologies Corp. 9.11.1 Biotii Technologies Corp. Company Details 9.11.2 Biotii Technologies Corp. Description and Business Overview 9.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction 9.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.11.5 Biotii Technologies Corp. Recent Development 9.12 Bristol-Myers Squibb 9.12.1 Bristol-Myers Squibb Company Details 9.12.2 Bristol-Myers Squibb Description and Business Overview 9.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction 9.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.12.5 Bristol-Myers Squibb Recent Development 9.13 Biogen Inc. 9.13.1 Biogen Inc. Company Details 9.13.2 Biogen Inc. Description and Business Overview 9.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction 9.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.13.5 Biogen Inc. Recent Development 9.14 GW Pharmaceuticals 9.14.1 GW Pharmaceuticals Company Details 9.14.2 GW Pharmaceuticals Description and Business Overview 9.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction 9.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2022 & 2035) 9.14.5 GW Pharmaceuticals Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/biosynthesis-of-cannabinoids-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/biosynthesis-of-cannabinoids-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors